Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Organ-on-Chip Market, by Type
1.4.2 Europe Organ-on-Chip Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Organ-on-Chip Market by Type
3.1 Europe Lung on chip Market by Country
3.2 Europe Heart on chip Market by Country
3.3 Europe Human on chip Market by Country
3.4 Europe Kidney on chip Market by Country
3.5 Europe Liver on chip Market by Country
3.6 Europe Intestine on chip Market by Country
Chapter 4. Europe Organ-on-Chip Market by Country
4.1 Germany Organ-on-Chip Market
4.1.1 Germany Organ-on-Chip Market by Type
4.2 UK Organ-on-Chip Market
4.2.1 UK Organ-on-Chip Market by Type
4.3 France Organ-on-Chip Market
4.3.1 France Organ-on-Chip Market by Type
4.4 Russia Organ-on-Chip Market
4.4.1 Russia Organ-on-Chip Market by Type
4.5 Spain Organ-on-Chip Market
4.5.1 Spain Organ-on-Chip Market by Type
4.6 Italy Organ-on-Chip Market
4.6.1 Italy Organ-on-Chip Market by Type
4.7 Rest of Europe Organ-on-Chip Market
4.7.1 Rest of Europe Organ-on-Chip Market by Type
Chapter 5. Company Profiles
5.1 Visikol, Inc.
5.1.1 Company Overview
5.2 CN Bio Innovations Ltd.
5.2.1 Company Overview
5.2.2 Recent strategies and developments:
5.2.2.1 Product Launches and Product Expansions:
5.2.2.2 Geographical Expansions:
5.3 Elveflow (Elvesys Group)
5.3.1 Company Overview
5.4 Emulate, Inc.
5.4.1 Company Overview
5.4.2 Recent strategies and developments:
5.4.2.1 Product Launches and Product Expansions:
5.5 Insphero AG
5.5.1 Company Overview
5.6 Mimetas B.V.
5.6.1 Company Overview
5.6.2 Recent strategies and developments:
5.6.2.1 Partnerships, Collaborations, and Agreements:
5.6.2.2 Product Launches and Product Expansions:
5.7 Nortis Inc.
5.7.1 Company Overview
5.8 Organovo Holdings, Inc.
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Research & Development Expenses
5.9 TARA Biosystems, Inc.
5.9.1 Company Overview
5.10. AxoSim, Inc.
5.10.1 Company Overview
Unique Offerings 
